ETF & Index Data Insights, News & Analysis | Ultumus

New Listings: A Fund Built to Take In Investors' Shares Tax-Free Warns That the IRS Has Called the Idea Potentially Abusive

Written by Bernie Thurston | Nov 20, 2026, 11:16:43 AM

Most prospectuses bury their tax risk on page forty. This one explains, in plain terms, that the IRS has published guidance describing structures like it as potentially abusive, and that the guidance could apply retroactively.

Alpha Architect US Equity 5 ETF (AAUD, Nasdaq)

The fund expects to acquire "substantially all of its assets through one or more in-kind contributions". In other words, investors hand over portfolios of shares they already own, receive ETF units in return, and hope that Section 351 of the tax code treats the swap as tax-free. I recently noted Avantis doing something similar with a core equity fund. The prospectus does not explain the 5 in the name, which leaves the reader to wonder about the other four.

Here the difference is the paragraph that follows. The prospectus cites Revenue Ruling 2026-20 and Notice 2026-62, in which the IRS describes similar structures as potentially abusive and says future guidance could apply retroactively. If the contributions do not qualify, the fund lists the consequences: corrected tax reporting, deficiency dividends and, at worst, loss of its status as a regulated investment company.

The proposed mitigation is to sell contributed securities for cash rather than distribute them in kind. The prospectus concedes that this could increase capital gains distributions and reduce tax efficiency. For a vehicle whose purpose is tax efficiency, that is a candid sentence.

The rest is cheap and modest. Total expenses are 0.11%, the universe is US stocks above $1 billion in market value, and there is a dividend-timing overlay that tries to replace holdings before their record dates. The sub-adviser "does not perform any type of fundamental or quantitative analysis" on the companies. Nobody claims to be picking stocks here. The skill on offer is in the paperwork.


The leveraged Anthropic wave (ANTT, ANTZ, ANUU, ANDD, ANSS and ATHX, Cboe BZX)

I recently described a triple-leveraged Anthropic product in London that held only cash while it waited for the shares to exist. The shares now exist, and the US industry has arrived in force: Tradr, Leverage Shares and Volatility Shares between them account for six of the new tickers here, and the wider count of daily leveraged and inverse funds on the stock runs well into double figures.

Each fund is a careful exercise in timing. Volatility Shares states that its 2x Anthropic ETF will not trade until two trading days after the IPO, which is an honest admission that a fund designed to double something needs that something to trade first. The same fund is classified as a commodity pool, which is a striking label for a bet on a software company. Tradr, meanwhile, says that Anthropic's listing "will go down as the seminal capital markets event" of the year, and has built two products for investors who disagree with each other about it.

The most sober entry is the Leverage Shares 1x Short Anthropic Daily ETF, which offers a simple, unleveraged inverse position for 0.99%. Its disclaimer still notes that an investor "could lose the full principal value" in one day if the stock more than doubles. In this corner of the market, that counts as the cautious option.


T-REX 2X Long Anthropic Daily Target ETF (CLAU, Cboe BZX)

REX has chosen its ticker from the product rather than the company. The fund page helpfully confirms that CLAU is not Anthropic's ticker, which is the kind of disclaimer that is only ever necessary when somebody expects to be misunderstood.

The prospectus gives the fund a 1.50% fee and the usual swap-based route to 200% of the daily return. It may also hold the stock directly, though it describes that as "typically less efficient". It also says the fund "could theoretically lose an amount greater than its net assets" after a sufficiently bad day, and, in different paragraphs, describes Anthropic both as a company expected to complete an IPO and as one already trading on Nasdaq. Both statements were true at some point. The prospectus simply kept them both.


Rho Protection I ETP (RHOP, SIX Swiss Exchange)

The issuer has not yet said much about this product. The index it is named after, however, already sits under a collateralised ETN on Xetra, and that sibling describes the strategy: 15 leading US blue chips, each wrapped in its own collar of bought puts and sold calls.

So the investor gives away the upside on each stock to pay for protection on the same stock, fifteen times over, and the sibling charges 1.50% a year to do it. That is a great deal of engineering to arrive at something that behaves a little like a cautious bond fund with American accents.